Mydekla 60 mg Wholesale Supplier
MyDekla (Daclatasvir), an NS5A replication complex inhibitor, is the first 12-week, all-oral therapy indicated for use with Sofosbuvir, for the treatment of hepatitis C (HCV) genotype 3 infections. The drug was manufactured by MyLan Pharmaceuticals.
- Generic Ledipasvir Sofosbuvir - The Life Changing Medicines For Hepatitis C Patients
- Geftinat (Gefitinib) 250mg Natco - Buy Lung cancer medicine from India
- What Women Need to Know to Improve Their Health ?
- Natdac 60mg Daclatasvir : A Promising Treatment For Patients With Chronic Hepatitis C
- The Better Way To Treat And Care Breast Cancer
4216/20, Ground Floor, 1 Ansari Road, Near Allahabad Bank, Daryaganj